US biotech Moderna said its Covid-19 vaccine had shown 94.5 per cent efficacy in clinical trials, in the second positive set of results for a potential coronavirus shot in the past eight days.
Last week, US pharmaceutical company Pfizer and Germany’s BioNTech also said their vaccine, which uses the same messenger RNA technology, was found to be more than 90 per cent effective.
The Moderna finding, hot on the heels of that breakthrough, will further boost optimism that the world can turn the corner in the management of the pandemic.
您已閱讀19%（535字），剩餘81%（2277字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。